Performance and Tolerability of the Medical Device LACRIACT

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 9, 2021

Primary Completion Date

December 18, 2022

Study Completion Date

November 28, 2023

Conditions
Dry EyeContact Lens Acute Red EyePhotophobiaDiscomfort
Interventions
DEVICE

LACRIACT

"LACRIACT is is a preservative free ophthalmic sterile medical device solution. The solution is packaged in closable vials of inert material that does not affect the contents (clear low-density polyethylene), each vial contains 0.5 ml of solution.~Eligible patients will start the treatment. Patients will receive the box of eye drops, and will be instructed on how to self-administer 1 drop in each eye 4 times a day for 30 days starting from the day following the visit."

Trial Locations (1)

88900

USOD Oculistica, Presidio Ospedaliero di Crotone, Ospedale San Giovanni di Dio, Crotone

All Listed Sponsors
collaborator

Opera CRO, a TIGERMED Group Company

OTHER

lead

Laboratórios Baldacci S.A

INDUSTRY

NCT06159569 - Performance and Tolerability of the Medical Device LACRIACT | Biotech Hunter | Biotech Hunter